Astec Lifesciences
Astec Lifesciences Limited, a prominent player in the agrochemical and pharmaceutical sectors, is headquartered in India. Established in 1994, the company has made significant strides in the development and manufacturing of a diverse range of active ingredients and intermediates. With a strong presence in both domestic and international markets, Astec Lifesciences focuses on crop protection, specialty chemicals, and custom synthesis. The company is renowned for its commitment to quality and innovation, offering unique products that cater to the evolving needs of the agricultural and pharmaceutical industries. Notable achievements include a robust portfolio of patented formulations and a reputation for excellence in regulatory compliance. As a key contributor to sustainable agriculture, Astec Lifesciences continues to strengthen its market position through strategic partnerships and a dedication to research and development.
DitchCarbon Score
How does Astec Lifesciences's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Astec Lifesciences's score of 18 is lower than 66% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Astec Lifesciences's reported carbon emissions
In 2023, Astec Lifesciences reported total carbon emissions of approximately 19,072,000 kg CO2e for Scope 1 and about 45,092,000 kg CO2e for Scope 3. This data reflects a significant carbon footprint, with Scope 1 emissions representing direct emissions from owned or controlled sources, while Scope 3 emissions encompass indirect emissions from the value chain. In 2022, the company recorded higher emissions, with Scope 1 at approximately 23,309,000 kg CO2e and Scope 3 at about 74,046,000 kg CO2e, indicating a reduction in Scope 1 emissions in 2023. However, no specific reduction targets or climate pledges have been disclosed, and there are no reported initiatives under the Science Based Targets initiative (SBTi) or other climate frameworks. Astec Lifesciences is a current subsidiary of Godrej Agrovet Limited, which may influence its climate commitments and reporting practices. The emissions data is cascaded from the parent company, reflecting the broader corporate family’s approach to sustainability. The company has not disclosed any Scope 2 emissions data, which typically includes indirect emissions from the generation of purchased electricity, steam, heating, and cooling consumed by the company. Overall, while Astec Lifesciences has shown some progress in reducing its Scope 1 emissions, further transparency regarding its climate commitments and reduction initiatives would enhance its sustainability profile.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | |
|---|---|---|
| Scope 1 | 23,309,000 | 00,000,000 |
| Scope 2 | - | - |
| Scope 3 | 74,046,000 | 00,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Astec Lifesciences is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
